loader from loading.io

Q&A With White House COVID-19 Response Coordinator Ashish Jha

Coronavirus (COVID-19) Q&A

Release Date: 05/18/2022

Association of New-Onset Seizures With SARS-CoV-2 Vaccines show art Association of New-Onset Seizures With SARS-CoV-2 Vaccines

Coronavirus (COVID-19) Q&A

Interview with Churl-Su Kwon, MD, MPH, author of Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hosted by Cynthia E. Armand, MD. Related Content:

info_outline Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy show art Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy

Coronavirus (COVID-19) Q&A

Benjamin D. Sommers, MD, PhD, of Harvard University, speaks with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, about differences in Medicaid enrollment as measured in surveys and administrative data. These differences have implications for estimating coverage now that the federal policy of continuous Medicaid eligibility during the COVID-19 pandemic has ended. Related Content:

info_outline February 2024 Medical News Summary show art February 2024 Medical News Summary

Coronavirus (COVID-19) Q&A

Rural Maternity Care Is in Crisis—Here’s What Could Help; Type and Severity of Immunodeficiency Affect Speed of SARS-CoV-2 Clearance, Study Finds Related Content:

info_outline Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents show art Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

Coronavirus (COVID-19) Q&A

Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:

info_outline Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic show art Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic

Coronavirus (COVID-19) Q&A

The COVID-19 pandemic has caused major disruptions in ambulatory care. In this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses how access to care and preventive services changed for different racial and ethnic groups in the US from 2019 to 2022. Related Content:

info_outline Safety and Effectiveness of Maternal and Child COVID-19 Vaccination show art Safety and Effectiveness of Maternal and Child COVID-19 Vaccination

Coronavirus (COVID-19) Q&A

Two recent studies find that COVID-19 vaccination during pregnancy is safe for infants and effective for children aged 1-4 years. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, discuss clinical and policy implications with Grace Lee, MD, MPH, professor of Pediatrics at Stanford University School of Medicine, Palo Alto, California. Related Content:

info_outline The Connection Between SARS-CoV-2 and Type 1 Diabetes Risk in Young Children show art The Connection Between SARS-CoV-2 and Type 1 Diabetes Risk in Young Children

Coronavirus (COVID-19) Q&A

During the COVID-19 pandemic, the incidence of diabetes in childhood increased. JAMA Associate Editor Anne R. Cappola, MD, ScM, and Ezio Bonifacio, PhD, from the Center for Regenerative Therapies at the Dresden University of Technology, discuss SARS-CoV-2 infection and its association with islet autoimmunity in early childhood. Related Content:

info_outline Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction show art Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction

Coronavirus (COVID-19) Q&A

Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content:

info_outline Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy show art Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy

Coronavirus (COVID-19) Q&A

In this interview, JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, explore with Erin K. McCreary, PharmD, and Atheendar S. Venkataramani, MD, PhD, how a large regional health system used a weighted lottery and intensive outreach to provide high-risk individuals in disadvantaged communities more equitable access to scarce monoclonal antibodies for preventing COVID-19. Related Content:

info_outline How Safe Were Kids in School During Phases of the Pandemic? show art How Safe Were Kids in School During Phases of the Pandemic?

Coronavirus (COVID-19) Q&A

JAMA Health Forum Editor John Ayanian, MD, and Deputy Editor Melinda Buntin, PhD, discuss with Sandra B. Nelson, MD (Massachusetts General Hospital, Boston), her JAMA Health Forum study of transmission of SARS-CoV-2 in schools in Massachusetts during 2 different phases of the COVID-19 pandemic. She found transmission rates were very low but varied by district and the availability of vaccines. Related Content:

info_outline
 
More Episodes

As the White House’s COVID-19 Response Coordinator, Ashish Jha, MD, MPH, plays a critical role in the federal government’s continued response to the pandemic. In this Q&A with JAMA Associate Editor Preeti Malani, MD, Jha details current thinking and federal planning around additional boosters, testing trends, and treatment for COVID-19.

Related Content: